Use of ultraviolet, near-ultraviolet and near infrared resonance raman spec-troscopy and fluorescence spectroscopy fro tissue interrogation of shock states, critical illnesses, and other disease states
First Claim
1. A tissue analysis method, comprising:
- interrogating a biological tissue with Raman spectroscopy and fluorescence spectroscopy to obtain spectroscopy results.
3 Assignments
0 Petitions
Accused Products
Abstract
In an emergency medicine patient, accurate measurement of change or lack thereof from non-shock, non-ischemic, non-inflammation, non-tissue injury, non-immune dysfunction conditions is important and is provided, as practical, real-time approaches for accurately characterizing a patient'"'"'s condition, using Raman (3) and/or fluorescence (30) spectroscopy with a high degree of accuracy. Measurement times are on the order of seconds. High-accuracy measurement is achieved with Raman spectroscopy interrogation of tissue. Simultaneous interrogation by NADH fluorescence spectroscopy may he used. Measurements may be non-invasive to minimally invasive. Preclinical (ultra-early) states of shock can be detected (5), severity can be determined, effectiveness of various treatments can be determined.
-
Citations
76 Claims
-
1. A tissue analysis method, comprising:
interrogating a biological tissue with Raman spectroscopy and fluorescence spectroscopy to obtain spectroscopy results. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)
-
32. A method of diagnosing shock, tissue ischemia, tissue injury, tissue inflammation, or tissue immune dysfunction, comprising:
-
(A) for a target molecule population, taking a sample Raman spectroscopy, and/or fluorescence spectroscopy, profile for a patient;
(B) comparing the sample spectroscopy profile with a pre-established Raman spectroscopy and/or fluorescence spectroscopy profile for the target molecule population under baseline conditions. - View Dependent Claims (33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 56, 57, 58, 59)
-
- 52. The method of claim 52, including Raman spectroscopy.
-
60. A spectroscopy comparative profile, comprising:
-
a pre-established Raman spectroscopy and fluorescence spectroscopy profile for a target molecule population under baseline conditions; and
a sample Raman spectroscopy and fluorescence spectroscopy profile for the target molecule population.
-
-
61. The comparative profile of claim 61, including a pre-established fluorescence spectroscopy profile for NADH under baseline conditions and a sample fluorescence profile for NADH.
-
62. A method of diagnosing abnormalities in vivo and in situ, comprising:
-
(A) for a target molecule population, taking a sample Raman spectroscopy and/or fluorescence spectroscopy profile for a patient;
(B) comparing the sample Raman spectroscopy or fluorescence spectroscopy profile with a pre-established Raman spectroscopy or fluorescence spectroscopy profile for the target molecule population under baseline conditions;
(C) using differences identified in said comparing step to identify an abnormality. - View Dependent Claims (63, 64, 65)
-
-
66. A medical measurement device comprising:
-
a spectrometer with multiple wavelength settings for resonance Raman spectroscopy; and
a biological probe electrically connected to the spectrometer. - View Dependent Claims (67, 68, 69)
-
-
70. A computer system comprising:
-
a database of stored baseline Raman spectroscopy and/or fluorescence spectroscopy profiles and a means to store patient Raman spectroscopy and/or fluorescence spectroscopy profiles. - View Dependent Claims (71)
-
-
72. A biological material analysis method, comprising:
interrogating a biological material with Raman spectroscopy and fluorescence spectroscopy to obtain spectroscopy results. - View Dependent Claims (73, 74, 75, 76)
Specification